HomeOpen Access NewsInfection Control

Infection Control

Scientists reveal new vaccine for recurring yeast infections

University of Georgia researchers have successfully created a vaccine that protects and treats vaginal yeast infections in mice.

What are the side effects of the Pfizer vaccine?

Here, we assess some of the most common side effects of the Pfizer and BioNTech COVID-19 vaccine.

Single COVID-19 vaccine dose reduces household transmission by 49%

New Public Health England (PHE) study finds that one dose of the COVID-19 vaccine reduces household transmission by up to 49%.

What are the side effects of the Moderna vaccine?

Here we list some of the most common and uncommon side effects of the Moderna vaccine and discuss the latest trials on pediatric participants.

Is the Indian ‘double mutation’ as dangerous as the UK mutation?

India broke records on Thursday (23 April) as more than 310,000 new COVID cases were documented in one day - is the Indian 'double mutation', B1617, as infectious as the UK mutation? 

UK mutation 45% more infectious than original COVID-19

The UK mutation of COVID-19, aka B117, has been found by scientists to be 45% more infectious than the original form of the virus.

Some countries can’t vaccinate population against COVID until 2023

In February, 16% of the world's population pre-ordered 70% of available COVID vaccines - now, researchers at Colombia University reveal that some poorer countries won't be able to vaccinate their population until 2023.

84% of young people willing to get vaccinated

Data from a MyVoice national survey has found that the percentage of young people who say they're willing to get vaccinated has risen to 84%.

Prioritising maternal and child health in the COVID-19 era

Mahesh Karra, Assistant Professor of Global Development Policy, discusses the importance of maternal and child health during the COVID pandemic.

Over 50% of healthcare workers report one symptom of PTSD

The US is facing a fourth wave of COVID-19, as emergency healthcare workers across the country continue to face the virus and experience levels of burnout that can lead to PTSD.

VMIC: A base for worldwide collaboration in the development of vaccines

We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.

How can touch-free technology help the NHS?

Here, Videx UK highlights how innovative hands-free door entry can help services return to normalcy post-COVID-19.

UV-C disinfection could be the solution to a COVID-safe return to school

Jarek Salek, Head of Engineering and Technical Operations at Uvisan, explains how UV-C cleaning in educational facilities can make shared equipment safe from COVID and help resume teaching that involves computers and other shared hardware.

Curative approach to severe autoimmune diseases

Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.

COVID-19 reveals the state of health and safety at work

European Trade Union Institute’s Marian Schaapman explains how COVID-19 reveals the state of health and safety in the workplace.

Application of ‘click chemistry’ ligation techniques to modified DNA and RNA

Professor Afaf El-Sagheer and Professor Tom Brown from the Department of Chemistry, Suez University and Oxford University describe their research, including the application of ‘click chemistry’ conjugation techniques to DNA.

Diphtheria slowly becomes resistant to antimicrobial treatment

There is a well-established diphtheria vaccine taken by millions of people, but researchers are now observing the disease evolving a resistance to antimicrobial treatment.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders